23 results on '"Buchler T"'
Search Results
2. 1449MO Updated efficacy of lenvatinib (LEN) + pembrolizumab (PEMBRO) vs sunitinib (SUN) in patients (pts) with advanced renal cell carcinoma (aRCC) in the CLEAR study
3. 1716P Primary resistance to front-line immune-based combinations in patients with advanced renal cell carcinoma (ARON-1)
4. Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study
5. 660P Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update
6. P-153 Regorafenib in the real-life clinical practice: data from the czech registry
7. P-005 Prognostic significance of the frequency of primary cilia in cells of small bowel and colorectal adenocarcinoma
8. 1897P Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations
9. 1674P VILP registry of patients with metastatic pancreatic cancer treated with pegylated liposomal irinotecan plus 5-fluoroucil and leucovorin in the Czech Republic
10. Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry
11. 1548P Favourable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic cancer
12. Overall and progression-free survival according to MSKCC scores in 1st line sunitinib treatment of metastatic renal cell carcinoma (mRCC)
13. Treatment sequences in metastatic renal cell carcinoma: Efficacy results from the Czech registry (RENIS)
14. Regorafenib for metastatic colorectal carcinoma: A registry-based analysis
15. Impact of delayed addition of anti-EGFR monoclonal antibodies on the outcome of first-line therapy in metastatic colorectal cancer patients: A retrospective registry-based analysis
16. The frequency of primary cilia, CD8+ tumor infiltrating lymphocytes and PD-1 expression in renal cell carcinoma of clear-cell type
17. Sequential therapy with bevacizumab and epidermal growth factor receptor-directed agents for metastatic colorectal carcinoma: A retrospective, registry-based analysis
18. 957P - Overall and progression-free survival according to MSKCC scores in 1st line sunitinib treatment of metastatic renal cell carcinoma (mRCC)
19. 892P - Treatment sequences in metastatic renal cell carcinoma: Efficacy results from the Czech registry (RENIS)
20. 491P - Impact of delayed addition of anti-EGFR monoclonal antibodies on the outcome of first-line therapy in metastatic colorectal cancer patients: A retrospective registry-based analysis
21. 468P - Regorafenib for metastatic colorectal carcinoma: A registry-based analysis
22. 165P - The frequency of primary cilia, CD8+ tumor infiltrating lymphocytes and PD-1 expression in renal cell carcinoma of clear-cell type
23. 518P - Sequential therapy with bevacizumab and epidermal growth factor receptor-directed agents for metastatic colorectal carcinoma: A retrospective, registry-based analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.